Home > Back to Publisher > Report Information

Creating a Success of ePedigree and RFID in Pharma (Strategic Focus)

Datamonitor
June 30, 2008
32 Pages - SKU: DFMN1819307

Abstract Table of Contents Search inside this report Related Reports

Introduction

The pharmaceutical industry is facing increasing pressures to introduce ePedigree and RFID solutions into their supply chains. This will create a number of opportunities for vendors to develop their business in the area, though it will prove very challenging.

Scope

Counterfeiting is an increasing problem for the pharmaceutical industry
Legislation could be key to the success of ePedigree and RFID
Implementations of ePedigree and RFID will not be simple
Geographic differences add an extra layer of complexity

Highlights

RFID has been a hyped solution in the pharmaceutical industry for a number of years. This report assesses the drivers and inhibitors behind ePedigree and RFID and the strategy vendors need to adopt to achieve success.

Reasons to Purchase

Understand the challenges facing pharma companies and how counterfeit drugs are effecting their business
Learn what makes vendors competitive who in the market is well positioned

Overview: Catalyst; Summary; Key Messages; Counterfeiting is an increasing problem for the pharmaceutical industry; Legislation could be key to the success of ePedigree and RFID; Implementations of ePedigree and RFID will not be simple; Geographic differences add an extra layer of complexity; Table of Contents; Table of figures; Market Opportunity; RFID can help solve many of pharma's pain points; RFID is a solution that is becoming more advanced and cost effective; ePedigree is a critical technology for the development of anti-counterfeiting measures in pharma; Understanding the difference between ePedigree and serialization; Pharma companies often choose 2D barcodes over RFID; The need for RFID is being driven from multiple directions but legislation is primary; The prevalence of counterfeiting is driving the need for RFID; The sale of drugs through the internet has proved a problem for preventing the spread of counterfeit drugs; The increase of legislation will help to drive the uptake of RFID; Uncertainty around legislation makes the market a challenging environment; RFID and ePedigree can help with drug recall; 2D barcodes do not offer a long term solution; There are a number of significant inhibitors holding the RFID market back; A number of pharma companies have a lack of confidence in RFID; RFID has yet to establish a compelling ROI; RFID is too dependent on the legislation that administrators may decide to introduce; The structure of the RFID market in pharma; Counterfeiting is a growing problem in the developing world; The US will be the dominant market, but implementations will often be global; Europe is introducing various legislation but some countries are not waiting for the EU; Customer Impact:; Pharma companies need to prepare for the introduction of a variety of legislation; The delay in the Californian legislation means that pharma companies will not miss the deadline; Preparation for the future is key; Irrespective of legislation, pharma companies should be forward thinking; Forward thinking means not shying away from innovative technology; Pharma manufacturers must not get caught up in a fight with wholesalers; Different types of companies need different policies; Not all vendors are suitable for ePedigree and RFID implementations; The complex pharma supply chain makes RFID implementations particularly challenging; Supply chains differ considerably across the markets; The landscape of future implementations is hard to judge; Vendors need to think carefully about their five year plan; Pharma manufacturers should seek to work with all stakeholders along the supply chain; The development of standards will prove crucial for future success; Competitive Landscape; Accenture; Positioning; Alien Technology; Positioning; Blue Vector; Positioning; Hewlett Packard Company; Positioning; SAP; Positioning; What does the future hold?; Go to Market; Vendors must not fall into the trap of becoming a solution looking for a problem; A deep knowledge of life sciences is key to prevent this; Vendors need to concentrate on bringing ePedigree and RFID to the wider market; An understanding of the different needs in each market is imperative; Well developed partnerships are crucial in order for ePedigree to succeed; Flexibility also remains important
APPENDIX: Definitions; Methodology; Further reading; Ask the analyst; Datamonitor consulting; Disclaimer
List of Figures: Figure 1: US pharmaceutical supply chain; Figure 2: UK pharmaceutical supply chain; Figure 3: Accenture SWOT analysis; Figure 4: Alien Technology SWOT analysis; Figure 5: Blue Vector SWOT analysis; Figure 6: Hewlett-Packard SWOT analysis; Figure 7: SAP SWOT analysis

Creating a Success of ePedigree and RFID in Pharma (Strategic Focus)

Share this report

Other tasks

Research Assistance

Related Markets

Manufacturing, Packaging & Detailing Reports

Free Alert Me service